Send us a text

Dr. Mia talks about the newly released preliminary results of anti-amyloid drug: lecanemab, the context of this newest drug development, and more questions than answers going forward.

News release of clinical trial Clarity AD (lecanemab) trial results
Biogen & Eisai's 50/50 relationship for lecanemab
Other trials including lecanemab
Biogen's recent $900 million lawsuit settlement due to improper physician payment
ARIA (Amyloid-related Imaging Abnormality): key side effects in lecanemab

Transcript & more at www.miayangmd.com
*Disclaimer: views expressed are Dr. Mia Yang's solely and do not represent her employer, National Institute of Health (NIH), or Patient-Centered Outcomes Research Institute (PCORI). Dr. Mia has no pharmaceutical company funding. 

Support the show

Video on Ask Dr. Mia YouTube channel
Transcripts on www.miayangmd.com. Transcripts are automatically generated and may contain minor inaccuracies.
Email: [email protected]
Opinions expressed are exclusive of Dr. Mia Yang and not reflective of her or guest speaker's employers or funders.